Lonza Group AG (LZAGY) Financials
LZAGY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | 20.3 billion | 9.0 billion |
| June 30, 2023 | 19.7 billion | 8.1 billion |
| Dec. 31, 2022 | 18.8 billion | 7.2 billion |
| Sept. 30, 2022 | ? | ? |
LZAGY Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | 170.1 million | 25.0 million |
| June 30, 2023 | -451.6 million | ? |
| Dec. 31, 2022 | -299.6 million | 34.6 million |
| Sept. 30, 2022 | ? | ? |
LZAGY Net Income
| Date | Net Income |
|---|---|
| Dec. 31, 2023 | 290.2 million |
| June 30, 2023 | 456.1 million |
| Dec. 31, 2022 | 777.7 million |
| Sept. 30, 2022 | 370.7 million |
LZAGY Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | 2.0 billion | - | 393.6 million |
| June 30, 2023 | 2.4 billion | - | - |
| Dec. 31, 2022 | 2.4 billion | - | 384.0 million |
| Sept. 30, 2022 | - | - | - |
LZAGY Shares Outstanding
LZAGY Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | 1.1 billion | 230.7 million | 243.8 million | 281.8 million |
| June 30, 2023 | 879.9 million | - | 552.8 million | - |
| Dec. 31, 2022 | 1.1 billion | 201.2 million | 227.1 million | 263.9 million |
| Sept. 30, 2022 | 505.0 million | - | - | - |
LZAGY Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | 4.3 billion | 3.3 billion |
| June 30, 2023 | 3.4 billion | 2.2 billion |
| Dec. 31, 2022 | 3.5 billion | 2.2 billion |
| Sept. 30, 2022 | - | - |
LZAGY
Price: $69.28
Dividend Yield: 0.81%
Forward Dividend Yield: 0.20%
Payout Ratio: 42.30%
Dividend Per Share: 0.14 USD
Earnings Per Share: 1.69 USD
P/E Ratio: 40.07
Exchange: PNK
Sector: Healthcare
Industry: Diagnostics & Research
Country: Switzerland
Volume: 52072
Ebitda: 1.0 billionMarket Capitalization: 50.1 billion
Average Dividend Frequency: 1
Years Paying Dividends: 18
DGR3: 11.65%
DGR5: 30.00%
DGR10: 30.00%